A citation-based method for searching scientific literature

Matthew Behr, Jing Zhou, Bing Xu, Hongwei Zhang. Acta Pharm Sin B 2021
Times Cited: 28



Yanfang Fu, Jennifer A Foden, Cyd Khayter, Morgan L Maeder, Deepak Reyon, J Keith Joung, Jeffry D Sander. Nat Biotechnol 2013
Times Cited: 1960




List of shared articles



Times cited


Progress of delivery methods for CRISPR-Cas9.
Wu Yang, Jiaqi Yan, Pengzhen Zhuang, Tao Ding, Yu Chen, Yu Zhang, Hongbo Zhang, Wenguo Cui. Expert Opin Drug Deliv 2022
1

In vivo delivery of CRISPR-Cas9 genome editing components for therapeutic applications.
Kun Huang, Daniel Zapata, Yan Tang, Yong Teng, Yamin Li. Biomaterials 2022
0

A dual conditional CRISPR-Cas9 system to activate gene editing and reduce off-target effects in human stem cells.
Seung Bum Park, Takuro Uchida, Samantha Tilson, Zongyi Hu, Christopher D Ma, Madeleine Leek, Michael Eichner, So Gun Hong, T Jake Liang. Mol Ther Nucleic Acids 2022
2

Delivery of CRISPR-Cas tools for in vivo genome editing therapy: Trends and challenges.
Eman A Taha, Joseph Lee, Akitsu Hotta. J Control Release 2022
11

CRISPR/Cas9 in the era of nanomedicine and synthetic biology.
Tiziana Julia Nadjeschda Schmidt, Barbara Berarducci, Soultana Konstantinidou, Vittoria Raffa. Drug Discov Today 2022
0